DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1**2 breast carcinoma

Author: Cabello Christopher M.   Lamore Sarah D.   Bair Warner B.   Davis Angela L.   Azimian Sara M.   Wondrak Georg T.  

Publisher: Informa Healthcare

ISSN: 1071-5762

Source: Free Radical Research, Vol.45, Iss.3, 2011-03, pp. : 276-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content